GlassScriptPhysician profile
Eric K Reynolds
NPI 1659565240
$924.22
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $86.66 · 2021: $53.51 · 2022: $54.78 · 2023: $497 · 2024: $32.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $441 · Food and Beverage: $88.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $440.70 |
| Food and Beverage | $88.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $487.02 | 2023-2024 | |
| Smith+Nephew, INC. | $326.94 | 2019-2024 | Collagenase Santyl |
| Merck Sharp & Dohme LLC | $22.87 | 2019 | |
| Integra Lifesciences Corporation | $21.02 | 2019 | |
| Kerecis Limited | $20.70 | 2020 | |
| Musculoskeletal Transplant Foundation INC. | $17.37 | 2019 | |
| Optinose US, INC. | $15.90 | 2022 | |
| Misonix INC | $12.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Reynolds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.